$BIIB Company News






Apple, Microsoft are not the keys to this week’s news
7:00 a.m. Today7:00 a.m. April 22, 2014
- Marek Fuchs




Long view on stocks is best during weak earnings season
6:00 a.m. April 20, 2014
- Wallace Witkowski





Biotech misses out on Nasdaq rally, sinks further into bear ground

4:58 p.m. April 14, 2014
- blogs.marketwatch.com




Herbalife sinks on probe fears; Zoe’s surges on debut
4:36 p.m. April 11, 2014
- Ben Eisen





Stocks fall for 3rd day in row; S&P 500 down for year again: stock market live blog recap

4:11 p.m. April 7, 2014
- blogs.marketwatch.com




Biotech bargain?
11:43 a.m. April 1, 2014
- The Trading Deck




Facebook, Biogen, Cal-Maine are stocks to watch
5:21 a.m. March 31, 2014
- Victor Reklaitis




U.S. stocks end week with losses
7:17 p.m. March 28, 2014
- Anora Mahmudova




Nasdaq pullback rife with opportunity
2:07 p.m. March 25, 2014
- The Trading Deck





Biotech comeback stalls as Wall Street starts to worry

12:45 p.m. March 25, 2014
- blogs.marketwatch.com




U.S. stocks fall; Nasdaq skids 1.2%
4:40 p.m. March 24, 2014
- Anora Mahmudova





Biotech has second straight sell-off; sector mutual funds take it on chin

10:40 a.m. March 24, 2014
- blogs.marketwatch.com




First Solar extends winning streak; Symantec plunges
3:06 p.m. March 21, 2014
- Ben Eisen





Investors let air out of biotech amid overheating, pricing concerns

1:42 p.m. March 21, 2014
- blogs.marketwatch.com




U.S. stocks rise; S&P 500 positive for the year
4:39 p.m. March 17, 2014
- Anora Mahmudova




Yahoo gains on Alibaba IPO; Plug Power loses momentum
4:17 p.m. March 17, 2014
- Saumya Vaishampayan




Keurig Green Mountain added to S&P 500 index
9:56 a.m. March 15, 2014
- MarketWatch.com




From every angle, technicals point to richer stocks
2:25 p.m. March 11, 2014
- The Trading Deck





Stocks close mostly higher after jobs report beats forecasts: stock market live blog recap

4:03 p.m. March 7, 2014
- blogs.marketwatch.com





Best stocks for legalized marijuana

1:37 p.m. Feb. 27, 2014
- blogs.marketwatch.com











Insider Trading Alert - BIIB, JAZZ And KWK Traded By Insiders

10:15 a.m. Today10:15 a.m. April 22, 2014
- TheStreet.com





Cytokinetics, Incorporated (CYTK) Jumps: Stock Up 13.5% - Tale of the Tape

9:39 a.m. Today9:39 a.m. April 22, 2014
- Zacks.com





Zacks Rank #1 Additions for Tuesday - Tale of the Tape

9:30 a.m. Today9:30 a.m. April 22, 2014
- Zacks.com





Sarepta Therapeutics (SRPT) Soars: Stock Up 39.3% - Tale of the Tape

8:51 a.m. Today8:51 a.m. April 22, 2014
- Zacks.com





ANI Pharmaceuticals, Inc. (ANIP) Looks Strong: Stock Soars 20.7% - Tale of the Tape

8:44 a.m. Today8:44 a.m. April 22, 2014
- Zacks.com





Should You Get Rid of Retrophin (RTRX) Now? - Tale of the Tape

8:41 a.m. Today8:41 a.m. April 22, 2014
- Zacks.com





Will Amgen (AMGN) Miss This Earnings Season? - Analyst Blog

6:20 p.m. April 21, 2014
- Zacks.com





Biotech Is Not A Popping Bubble: Buy The Dip While You Can

2:34 p.m. April 21, 2014
- Seeking Alpha





Will Gilead (GILD) Beat Q1 Earnings? - Analyst Blog

10:50 a.m. April 21, 2014
- Zacks.com





Gilead heads Citi's 20 best stocks in America

10:28 a.m. April 21, 2014
- Seeking Alpha





3 Stocks Reiterated As A Buy: MU, VZ, BIIB

9:59 a.m. April 21, 2014
- TheStreet.com





Today's Market: Other Potential Buyout Targets For Pfizer

8:54 a.m. April 21, 2014
- Seeking Alpha





Biogen Idec Signs License Agreement With Amunix for XTENylated Factor VIII; Amunix Could Recieve up to $39M

7:02 a.m. April 21, 2014
- benzinga.com





Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

11:12 a.m. April 18, 2014
- Investors Business Daily





Xenoport's Path Is Long, But The Potential Is There

8:31 p.m. April 17, 2014
- Seeking Alpha





AbbVie Candidate in Pivotal Study - Analyst Blog

12:32 p.m. April 17, 2014
- Zacks.com





Biotech Stock Mailbag: NeoStem, Gilead and the Importance of Big-Cap Biotech Earnings

9:18 a.m. April 17, 2014
- TheStreet.com





Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog

10:07 a.m. April 16, 2014
- Zacks.com





'Fast Money' Recap: Impressed by Yahoo!

5:00 a.m. April 16, 2014
- TheStreet.com





Will Abbott Labs (ABT) Disappoint This Quarter? - Analyst Blog

11:30 a.m. April 15, 2014
- Zacks.com










Biogen Idec Signs License Agreement With Amunix for XTENylated Factor
VIII
8:02 a.m. April 21, 2014
- Marketwire




RBCC Bioprinting Partner Expands Brand Awareness Campaign
4:28 a.m. April 16, 2014
- BusinessWire - BZX




Surveyed European Neurologists Expect to Prescribe Biogen Idec's Tecfidera to 16 Percent of their Diagnosed Relapsing-Remitting Multiple Sclerosis Patients in the Next 12 Months
1:00 p.m. April 15, 2014
- PR Newswire - PRF




Legal Updates, Stock Price Movements, New Awareness Campaigns, and Senior-level Appointments - Analyst Notes on Mylan, WellPoint, Forest, Novatis and Intercept
8:00 a.m. April 15, 2014
- PR Newswire - PRF




Biogen Idec to Present New Clinical Data from Its Robust Neurology
Portfolio at AAN Annual Meeting
7:30 a.m. April 14, 2014
- BusinessWire - BZX




JPMorgan Chase First Quarter Earnings Falls 20 Percent; FBI Probes Herbalife Business
12:36 a.m. April 14, 2014
- ACCESSWIRE




Pfizer’s Ian Read Becomes PhRMA Board Chairman; Ken Frazier, George
Scangos Assume New Posts
9:00 a.m. April 11, 2014
- BusinessWire - BZX




Biogen Idec Names Adam M. Koppel as SVP and Chief Strategy Officer
7:30 a.m. April 10, 2014
- BusinessWire - BZX




Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase-3 paediatric study of investigational therapy Eloctate(TM) (rFVIIIFc) for haemophilia A
7:06 a.m. April 10, 2014
- Thomson Reuters ONE




Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety
Results from Phase 3 Pediatric Study of Investigational Therapy Eloctate™
(rFVIIIFc) for Hemophilia A
7:00 a.m. April 10, 2014
- BusinessWire - BZX




RBCC and n3D Seek Out Additional Capital
5:00 a.m. April 9, 2014
- BusinessWire - BZX




Earnings Release Schedules, Product Portfolio Expansion, Initiatives and Stock Price Movements - Analyst Notes on Biogen Idec, Bristol-Myers, Regeneron Pharma, Illumina, West Pharma Services
8:00 a.m. April 8, 2014
- PR Newswire - PRF




Bioprinting Investment Puts RBCC at Forefront of 3-D Revolution
5:00 a.m. April 3, 2014
- BusinessWire - BZX




Biogen Idec to Report First Quarter 2014 Financial Results on April
23, 2014
4:01 p.m. March 31, 2014
- BusinessWire - BZX




Sobi: US FDA approves Alprolix(TM)
2:05 a.m. March 31, 2014
- GlobeNewswire




Sobi: US FDA approves Alprolix(TM)
2:01 a.m. March 31, 2014
- Thomson Reuters ONE




FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy
to Reduce Bleeding Episodes with Prophylactic Infusions Starting at
Least a Week Apart
6:34 p.m. March 28, 2014
- BusinessWire - BZX




FDA Approves Biogen Idec’s ALPROLIX™, the First Hemophilia B Therapy
to Reduce Bleeding Episodes with Prophylactic Infusions Starting at
Least a Week Apart
6:24 p.m. March 28, 2014
- BusinessWire - BZX




Critical Alerts For DirecTV, Biogen Idec, Time Warner, Isis Pharmaceuticals, and DreamWorks Animation Released By InvestorsObserver
9:31 a.m. March 27, 2014
- PR Newswire - PRF




Pharmaceutical Executive to Unveil Brand of the Year Award Recipients at iPharma 2014: CBI's Marketing Innovation Summit
12:11 p.m. March 26, 2014
- PR Newswire - PRF